Moreover, Cr supplementation increased the p-IRS-1, GLUT2, and GLUT4 expression in the liver of various animal models of metabolic disorders, such as NAFLD, obesity, T2DM and metabolic syndrome, and thus lowering the hepatic TG levels of these models (23–27). The gene discussed is SLC2A2; the disease is obesity disorder.